Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
170.6 USD | -0.09% |
|
-0.94% | +10.03% |
06-25 | FDA Again Rejects AbbVie Parkinson's Drug/Pump Combo -- Update | DJ |
06-25 | AbbVie Issues Regulatory Update on New Drug Application for ABBV-951 to Treat Parkinson's Disease | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.03% | 302B | |
+55.30% | 815B | |
+45.28% | 654B | |
-6.67% | 354B | |
+21.56% | 337B | |
+17.71% | 247B | |
+2.09% | 229B | |
+12.95% | 219B | |
+9.52% | 171B | |
-3.53% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc., ImmunoGen, Inc. - M&A Call